Opioid Agonist Treatment

The Correctional Service of Canada (CSC) introduced methadone over 20 years ago. Since that time, CSC has been providing opioid agonist treatment (OAT) (methadone and buprenorphine-naloxone) to incarcerated persons with an opioid use disorder.

Over the past three years, in the context of the Canadian opioid crisis, the demand for treatment has dramatically increased and continues to increase.

The following graphs show a point-in-time snapshot of the number of individuals, by institution, on OAT and the number of individuals on the wait list.

Date modified: